The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

  • See Evidence submitted by expert panel for details.

Variant: NM_000545.8(HNF1A):c.1623+3A>G

CA10587145

256598 (ClinVar)

Gene: HNF1A
Condition: monogenic diabetes
Inheritance Mode: Autosomal dominant inheritance
UUID: 4d08e15d-7c27-4174-9937-728646b86912
Approved on: 2022-05-03
Published on: 2022-05-03

HGVS expressions

NM_000545.8:c.1623+3A>G
NM_000545.8(HNF1A):c.1623+3A>G
NC_000012.12:g.120999392A>G
CM000674.2:g.120999392A>G
NC_000012.11:g.121437195A>G
CM000674.1:g.121437195A>G
NC_000012.10:g.119921578A>G
NG_011731.2:g.25647A>G
ENST00000257555.11:c.1623+3A>G
ENST00000257555.10:c.1623+3A>G
ENST00000540108.1:c.*1063+3A>G
ENST00000541395.5:c.1626A>G
ENST00000543427.5:c.1086+3A>G
ENST00000544413.2:c.1623+3A>G
ENST00000560968.5:n.1440+3A>G
ENST00000615446.4:c.411+3A>G
ENST00000617366.4:c.*32+3A>G
NM_000545.5:c.1623+3A>G
NM_000545.6:c.1623+3A>G
NM_001306179.1:c.1623+3A>G
NM_001306179.2:c.1623+3A>G

Uncertain Significance

Met criteria codes 2
BP4 PM2_Supporting

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
Monogenic Diabetes VCEP
The c.1623+3A>G variant in the HNF1 homeobox A gene, HNF1A, is predicted to remove a canonical splice donor site in intron 8 of NM_000545.8. This variant is absent from gnomAD v2.1.1 (PM2_Supporting). The computational splicing predictor SpliceAI gives a score of 0.0 for donor loss, suggesting that the variant has no impact on splicing (BP4). In summary, c.1623+3A>G meets the criteria to be classified as a variant of uncertain significance for monogenic diabetes. ACMG/AMP criteria applied, as specified by the ClinGen MDEP (specification version 1.1, approved 9/30/2021): PM2_Supporting, BP4.
Met criteria codes
BP4
The computational splicing predictor SpliceAI gives a score of 0.00 for donor/acceptor loss, suggesting that the variant has no impact on splicing.
PM2_Supporting
Absent from gnomAD.
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.